Real-life comparison of efficacy and safety profiles of two prolonged-release tacrolimus formulations in de novo kidney transplant recipients: 24 months of follow-up

INTRODUCTION: Calcineurin inhibitors constitute a cornerstone of immunosuppressive therapy in kidney transplant recipients. There are two main formulations of tacrolimus (Tac) which exhibit a prolonged-release mode of action: Advagraf(®) (MR-4) and Envarsus(®) (LCPT). However, they are not bioequiva...

Descripción completa

Detalles Bibliográficos
Autores principales: Czarnecka, Paulina, Czarnecka, Kinga, Baczkowska, Teresa, Lagiewska, Beata, Durlik, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858018/
https://www.ncbi.nlm.nih.gov/pubmed/36662740
http://dx.doi.org/10.1371/journal.pone.0278894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858018/
https://www.ncbi.nlm.nih.gov/pubmed/36662740
http://dx.doi.org/10.1371/journal.pone.0278894

Ejemplares similares